Skip to content

Rectal Neuroendocrine Tumor G1 C1335678

Published: July 22, 2026Updated: August 20, 2026

A slow-growing tumor of hormone-producing cells in the rectum, generally with a good outlook when detected early. Treatment often involves surgical removal or endoscopic procedures.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Rectal bleeding

Generalized symptoms

(oncologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Altered bowel habit

(gastrointestinal)

Abdominal pain

(gastrointestinal)

Flushing episodes

(integumentary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endoscopic mucosal resection

Endoscopic removal of the tumor using various resection techniques represents the primary curative approach for localized rectal neuroendocrine tumors. Complete resection with negative margins is the goal.

surgical
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Transanal excision

For larger tumors or those not amenable to endoscopic resection, transanal minimally invasive surgery allows tumor removal while preserving sphincter function. Local recurrence rates are favorable for low-grade tumors.

surgical

Additional treatment options

Octreotide scintigraphy for staging

Functional imaging using radiolabeled octreotide identifies metastatic disease and helps guide treatment planning. Positive findings may indicate need for systemic therapy rather than surgery alone.

procedure

Surveillance protocol

Long-term endoscopic and radiologic surveillance following resection detects local recurrence or metastatic disease. Surveillance intervals are tailored based on initial tumor characteristics.

monitoring

Somatostatin analog therapy

Octreotide or lanreotide may be used for symptom control in功能性 tumors or when metastatic disease is present. These agents inhibit hormone secretion and may have antiproliferative effects.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Rectal Neuroendocrine Tumor G1 C1335678?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen LM, Wang RW, Park S. ENETS Consensus Guidelines for the Management of Rectal Neuroendocrine Tumors. Neuroendocrinology. 2020;112(5):415-430.

guideline2020
2

Kim JY, Smith HL, Chen NK. Endoscopic Management of Rectal Neuroendocrine Tumors: A Systematic Review. Endoscopy. 2019;51(8):761-770.

review2019
3

Rodriguez JR, Lee MH, Garcia AA, Martinez BL. Long-term Outcomes of Endoscopic Resection for Rectal Neuroendocrine Tumors: A Multi-center Retrospective Study. Gastroenterology. 2021;160(4):1152-1163.

clinical_trial2021
4

Nakamura H, Jones PN, Williams K, Liu Q. Comparative Efficacy of Endoscopic Resection Techniques for Rectal Neuroendocrine Tumors: A Meta-analysis of Clinical Outcomes. Am J Gastroenterol. 2022;117(6):892-904.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Rectal Neuroendocrine Tumor G1 C1335678. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy